Axcelis Technologies (ACLS) Guides Q4 Revenue Ahead of Views

Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it was updating guidance for the fourth quarter of 2015, prior to presenting at the 18th Annual Needham Growth Conference this week.

The Company now expects fourth quarter revenue of approximately $70 million, gross margins in the low 30% range and operating profit of approximately $2 million. Earnings per share are expected to be breakeven to $0.01 and our cash balance will be approximately $85 million.

Street = Q4 revenue of $62.3 million and EPS of $0.00.

Kevin Brewer, executive vice president and chief financial officer said, "Purion systems sales have been the driver of our top line in 2015. Gross margins in the fourth quarter will be slightly lower than guidance, impacted by the closure of one of our outstanding Purion H evaluation tools one quarter sooner than expected. We are pleased that 2015 has been a positive year for Axcelis in terms of market share growth and improved financial performance."

You May Also Be Interested In

• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Cal-Maine Foods adds two independent directors, expanding board to ten
• Nike names former Pfizer CFO David Denton as new finance chief